Help make sure prostate cancer diagnosis is never left to chance
If a man has a high PSA level, he’ll be sent for an MRI scan as part of his diagnostic tests. The scan will help to identify if prostate cancer might be the cause, and, if a biopsy is needed, where to take it. This means an MRI scan is vital to the way we diagnose prostate cancer.
Now we need to make sure that these scans are as accurate as possible, so that men are given a safe and accurate diagnosis. We’ve done a lot, but we need to do more.
Early diagnosis could prevent up to 40% of prostate cancer deaths – that’s thousands of lives saved each year. Will you help ensure that the diagnostic pathway is the best that it can possibly be for all men?
Your support today can help improve and personalise the way men are treated with radiotherapy. Will you help give men the reassurance that their cancer will not return?
Revolutionising the diagnostic pathway
Dr Tristan Barrett, Academic Radiologist at the University of Cambridge, is using artificial intelligence (AI) to develop a tool that could ensure that MRI scans for prostate cancer are consistently high-quality.
This research could revolutionise prostate cancer diagnosis by ensuring that every hospital is consistently producing the best possible MRI images – making sure that all men receive the most accurate diagnosis possible, and even saving men from the risk of a missed diagnosis.
You can read more about his research here.
Nationwide MRI scans that are both fast and accurate will be vital as begin our once-in-a-generation £42 million TRANSFORM clinical trial. By comparing the most promising tests and providing definitive evidence, TRANSFORM aims to find the best way to screen men for prostate cancer. So that, one day, all men at risk are invited for regular tests to find aggressive cancers in time for a cure. This is urgently needed for men.
Will you help make a screening programme a reality for men?
Paul's story
In 2021, Paul Dennington was referred for a PSA blood test after some pain in his groin. His PSA score was 174. Following a biopsy, MRI scan, and some further tests, Paul was given the devastating news that no man wants to hear – he was diagnosed with stage 4 prostate cancer that had spread to his lymph nodes, and was incurable.
Paul says: “My prostate cancer was caught by chance. If I’d been invited for screening, then potentially my cancer would have been caught earlier and I would be facing a very different prognosis.”
For too many men, their prostate cancer diagnosis is left to chance. It isn’t good enough. That’s why we’re committed to improving the whole diagnostic pathway for all men and giving men the screening programme they deserve.
By supporting research like Dr Barrett’s, you’re funding the future of prostate cancer diagnosis that can change, and save, the lives of thousands of men.
